| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/03/2004 | EP1393739A1 Liver generation promoter |
| 03/03/2004 | EP1393723A2 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces |
| 03/03/2004 | EP1393721A1 Dosage form of powder agglomerates |
| 03/03/2004 | EP1393077A2 Method for identifying ligands for g protein coupled receptors |
| 03/03/2004 | EP1393075A2 Methods of screening and using inhibitors of angiogenesis |
| 03/03/2004 | EP1392867A2 Antisense modulation of ptp1b expression |
| 03/03/2004 | EP1392862A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 03/03/2004 | EP1392852A2 Nucleic acid-associated proteins |
| 03/03/2004 | EP1392846A2 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 03/03/2004 | EP1392845A2 A g-protein coupled receptor and uses therefor |
| 03/03/2004 | EP1392844A2 Use of hmg fragments as anti-inflammatory agents |
| 03/03/2004 | EP1392840A2 Method for producing proteins by fermentation of microorganisms from the thermus family, the protein mixture thus obtained and cosmetic compositions containing same |
| 03/03/2004 | EP1392830A2 Interleukin-18 mutants, their production and use |
| 03/03/2004 | EP1392829A2 Compositions and methods relating to lung specific genes and proteins |
| 03/03/2004 | EP1392828A2 Screens and assays for agents useful in controlling parasitic nematodes |
| 03/03/2004 | EP1392827A2 Destruction of prions using vibriolysin or variants thereof |
| 03/03/2004 | EP1392826A2 Bifunctional fusion proteins with glucocerebrosidase activity |
| 03/03/2004 | EP1392818A1 Chimeric immunoreceptor useful in treating human cancers |
| 03/03/2004 | EP1392817A2 Human secreted proteins |
| 03/03/2004 | EP1392733A2 Mammalian tumor susceptibility gene products and their uses |
| 03/03/2004 | EP1392731A2 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 03/03/2004 | EP1392730A2 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent |
| 03/03/2004 | EP1392729A2 Use of a peptide which activates guanylate-cyclase c for the treatment of respiratory airway problems via the airways, medicament, inhalation devices and method of diagnosis |
| 03/03/2004 | EP1392727A1 Production of a stress protein |
| 03/03/2004 | EP1392726A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 03/03/2004 | EP1392722A2 Echinocandin process |
| 03/03/2004 | EP1392721A1 Peptides and their use as inhibitors of hepatitis c virus ns3 protease |
| 03/03/2004 | EP1392720A2 Dipeptide derivatives having a n-terminal 2-thioacyl group as vasopeptidase inhibitors |
| 03/03/2004 | EP1392717A1 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins |
| 03/03/2004 | EP1392716A1 Isolated human secreted proteins nucleic acid molecules encoding human secreted proteins and uses thereof |
| 03/03/2004 | EP1392639A1 Pyruvate derivatives |
| 03/03/2004 | EP1392389A2 Microprojection array having a beneficial agent containing coating |
| 03/03/2004 | EP1392366A1 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 03/03/2004 | EP1392365A2 Compositions and therapeutical use of polynucleotides encoding tcrs |
| 03/03/2004 | EP1392361A1 Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26 |
| 03/03/2004 | EP1392358A2 Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof |
| 03/03/2004 | EP1392354A2 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds |
| 03/03/2004 | EP1392353A2 Composition containing phytase |
| 03/03/2004 | EP1392352A1 Use of an antioxidant for treating and/or preventing surface ocular disorders |
| 03/03/2004 | EP1392351A2 Chemokines as adjuvants of immune response |
| 03/03/2004 | EP1392350A2 Optimization of the molecular properties and formulation of proteins delivered by inhalation |
| 03/03/2004 | EP1392349A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 03/03/2004 | EP1392348A1 Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists |
| 03/03/2004 | EP1392347A2 Method of preventing cell death using segments of neural thread proteins |
| 03/03/2004 | EP1392346A2 Composition and method for enhancing elasticity of tissue |
| 03/03/2004 | EP1392345A2 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis |
| 03/03/2004 | EP1392344A1 Method of modulating the activity of calcium channels in cardiac cells and reagents therefor |
| 03/03/2004 | EP1392341A2 Pharmaceutical composition containing a stabilised mrna which is optimised for translation in the coding regions thereof |
| 03/03/2004 | EP1392340A2 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |
| 03/03/2004 | EP1392336A1 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof |
| 03/03/2004 | EP1392333A2 Manipulation of arterial-venous identity |
| 03/03/2004 | EP1392321A1 Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids |
| 03/03/2004 | EP1392317A2 Substituted 1-benzazepines and derivatives thereof |
| 03/03/2004 | EP1392305A2 Methods for treating neurodegenerative diseases including alzheimer's |
| 03/03/2004 | EP1392288A2 Medicament containing an effector of the glutathione metabolism together with $g(a)-lipoic acid for treating diabetes mellitus |
| 03/03/2004 | EP1392279A1 Trimethyl lock based tetrapartate prodrugs |
| 03/03/2004 | EP1392275A1 Use of protein and essential amino acids to treat amenorrhea and related disorders |
| 03/03/2004 | EP1392272A1 Permeation enhancers |
| 03/03/2004 | EP1392255A1 Nanoparticles made of protein with coupled apolipoprotein e for penetration of the blood-brain barrier and methods for the production thereof |
| 03/03/2004 | EP1392244A2 Pharmaceutical compositions |
| 03/03/2004 | EP1392241A2 System for osmotic delivery of pharmaceutically active agents |
| 03/03/2004 | EP1392230A1 Methods for treating or preventing diseases of the oral cavity |
| 03/03/2004 | EP1392204A2 Bifunctional energy-reversible acyl-compositions |
| 03/03/2004 | EP1196440B1 Therapeutic peptides derived from subsequences of bpi |
| 03/03/2004 | EP1149167B1 Viral vaccine |
| 03/03/2004 | EP1140020B1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 03/03/2004 | EP1119252A4 Use of melanin for inhibition of angiogenesis and macular degeneration |
| 03/03/2004 | EP1109571B1 Methods of treating salt-dependent hypertension |
| 03/03/2004 | EP1076645B1 Process for the preparation of methyl(2s)-2-[(3r)-3-(n-[tert-butyloxycarbonyl]-amino) -2-oxopyrr olidin-1-yl]propionate |
| 03/03/2004 | EP1073426B1 Pharmaceutical cyclosporin formulation with improved biopharmaceutical properties, improved physical quality and greater stability, and method for producing said formulation |
| 03/03/2004 | EP1062224A4 Modified factor viii |
| 03/03/2004 | EP1047437A4 Sea cucumber carotenoid lipid fraction products and methods of use |
| 03/03/2004 | EP1037655B1 use of novel ligands of the neuropeptide receptor hfgan72 and antagonists thereof in therapy |
| 03/03/2004 | EP1019025B1 Peptide/lipid complex formation by co-lyophilization |
| 03/03/2004 | EP1015017B1 Implantable system with drug-eluting cells for on-demand local drug delivery |
| 03/03/2004 | EP1011716B9 Neuromedin b receptor antagonists |
| 03/03/2004 | EP0948518B1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 03/03/2004 | EP0938341B1 Compositions and methods for altering the biodistribution of biological agents |
| 03/03/2004 | EP0866726B1 Pulmonary administration of dry powder alpha 1-antitrypsin |
| 03/03/2004 | EP0859628B9 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 03/03/2004 | EP0832900B1 Peptide and method of obtaining it |
| 03/03/2004 | EP0797447B1 Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides |
| 03/03/2004 | EP0733103B1 Generation of high titers of recombinant aav vectors |
| 03/03/2004 | EP0719150B1 Cellular vaccine and its use for the treatment of solid tumor malignancies |
| 03/03/2004 | EP0636028B1 Self-assembling polynucleotide delivery system comprising an amphiphatic cationic peptide |
| 03/03/2004 | EP0613375B1 Pharmaceutical lysine-containing polypeptide compositions and the use thereof |
| 03/03/2004 | CN1479871A Diagnostic and theraputic methods based on L1 adhesion molecule for ovarian and endometrial tumors |
| 03/03/2004 | CN1479788A Lactic acid bacteria capable of reducing indvidual's tendency to develop allergic reactions |
| 03/03/2004 | CN1479715A Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 03/03/2004 | CN1479638A Improvement of graft acceptance through manipulation of thymic regeneration |
| 03/03/2004 | CN1479632A Complexes for transferring necleic acids into cells |
| 03/03/2004 | CN1479629A Combinations and compositions which interfere with VEGF/VEFG and anglopoietin/Tie receptor function and their use (II) |
| 03/03/2004 | CN1479627A Method of protein purification and recovery |
| 03/03/2004 | CN1479622A Treatment of cancers by aplidine in conjunction with myoprotector |
| 03/03/2004 | CN1479618A Treatment of sexual dysfunction using boonbesin antagonist |
| 03/03/2004 | CN1479612A Pharmaceutical compositions for oral delivery of pharmacologically active agents |
| 03/03/2004 | CN1479609A Oral delivery of peptide |
| 03/03/2004 | CN1478890A Fermented soya bean thromboembolism enzyme and polynucleotide for coding said enzyme |
| 03/03/2004 | CN1478792A Oyster low molecular active peptide and its preparation method and application in the preparation of anticancer medicine |
| 03/03/2004 | CN1478548A compound pepsin powder for treating child dyspepsia and its preparation method |